Zepp Health (ZEPP) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Zepp Health Corporation faced a 56% revenue decline in the second quarter of 2024 compared to the previous year, reporting $40.6 million in revenue and a significant drop in units shipped. Despite this, the company achieved a record-high gross margin of 40.3%, driven by a strategic focus on self-branded products and a reduction in clearance sales. The firm anticipates continued gross margin improvement and is preparing to launch new AI-integrated products in the wearable tech market.
For further insights into ZEPP stock, check out TipRanks’ Stock Analysis page.
